{"filing":{"accession_number":"0001539497-26-002373","cik":"0001826892","ticker":"BCAB","company_name":"BioAtla, Inc.","form":"8-K","filing_date":"2026-08-28","report_date":"2026-08-26","primary_document":"n5620_x8-8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726002373/n5620_x8-8k.htm"},"events":[{"id":30195,"run_id":27680,"accession_number":"0001539497-26-002373","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"The filing discloses that the Nasdaq Listing Council has affirmed a determination to delist BioAtla's common stock from Nasdaq effective August 31, 2026, due to non-compliance with the $1.00 bid price requirement and $2.5 million stockholders' equity requirement. The Company expects trading suspension on Nasdaq and transfer to OTC Markets, which the filing acknowledges \"may have a material adverse effect on the trading price and volume for the Common Stock.\" This is a definitive delisting notice, not merely a risk or warning.","company_name":"BioAtla, Inc.","ticker":"BCAB","filing_date":"2026-08-28","form":"8-K","submitted_at":null,"items":[{"id":32730,"accession_number":"0001539497-26-002373","item_number":"3.01","item_title":"Notice","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"The filing discloses that the Nasdaq Listing Council has affirmed a determination to delist BioAtla's common stock from Nasdaq effective August 31, 2026, due to non-compliance with the $1.00 bid price requirement and $2.5 million stockholders' equity requirement. The Company expects trading suspension on Nasdaq and transfer to OTC Markets, which the filing acknowledges \"may have a material adverse effect on the trading price and volume for the Common Stock.\" This is a definitive delisting notice, not merely a risk or warning.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T12:03:51.020327+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32730,"accession_number":"0001539497-26-002373","item_number":"3.01","item_title":"Notice","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"The filing discloses that the Nasdaq Listing Council has affirmed a determination to delist BioAtla's common stock from Nasdaq effective August 31, 2026, due to non-compliance with the $1.00 bid price requirement and $2.5 million stockholders' equity requirement. The Company expects trading suspension on Nasdaq and transfer to OTC Markets, which the filing acknowledges \"may have a material adverse effect on the trading price and volume for the Common Stock.\" This is a definitive delisting notice, not merely a risk or warning.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T12:03:51.020327+00:00","company_name":"BioAtla, Inc.","ticker":"BCAB","filing_date":"2026-08-28"}]}